Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 18 04:00PM ET
155.05
Dollar change
-2.37
Percentage change
-1.51
%
IndexS&P 500 P/E14.43 EPS (ttm)10.74 Insider Own4.59% Shs Outstand80.54M Perf Week-10.64%
Market Cap12.40B Forward P/E11.91 EPS next Y13.01 Insider Trans-10.13% Shs Float76.33M Perf Month-5.94%
Income936.34M PEG0.97 EPS next Q2.03 Inst Own92.77% Short Float5.96% Perf Quarter-1.42%
Sales12.82B P/S0.97 EPS this Y14.21% Inst Trans-3.56% Short Ratio6.23 Perf Half Y3.39%
Book/sh1.50 P/B103.10 EPS next Y17.72% ROA5.26% Short Interest4.55M Perf Year25.64%
Cash/sh11.64 P/C13.32 EPS next 5Y14.87% ROE159.08% 52W Range118.56 - 179.60 Perf YTD3.68%
Dividend Est.1.67 (1.07%) P/FCF8.42 EPS past 5Y15.27% ROI8.14% 52W High-13.67% Beta0.96
Dividend TTM- Quick Ratio1.21 Sales past 5Y2.41% Gross Margin27.26% 52W Low30.78% ATR (14)5.62
Dividend Ex-Date- Current Ratio1.26 EPS Y/Y TTM45.02% Oper. Margin15.25% RSI (14)34.26 Volatility3.07% 2.49%
Employees76000 Debt/Eq99.63 Sales Y/Y TTM5.56% Profit Margin7.31% Recom2.91 Target Price169.14
Option/ShortYes / Yes LT Debt/Eq94.00 EPS Q/Q90.44% Payout0.00% Rel Volume2.38 Prev Close157.42
Sales Surprise1.01% EPS Surprise5.35% Sales Q/Q4.73% EarningsFeb 13 AMC Avg Volume730.34K Price155.05
SMA20-9.84% SMA50-4.13% SMA2001.94% Trades Volume1,736,974 Change-1.51%
Date Action Analyst Rating Change Price Target Change
Mar-06-24Initiated Barclays Equal Weight $133
Aug-07-23Upgrade UBS Neutral → Buy $100 → $142
Nov-01-22Downgrade Deutsche Bank Buy → Hold $97 → $72
Oct-31-22Downgrade UBS Buy → Neutral $117 → $74
Aug-19-22Resumed UBS Buy $106 → $117
Jun-21-22Reiterated BofA Securities Underperform $110 → $90
Sep-10-21Initiated Cowen Market Perform $145
Aug-12-21Downgrade Barclays Overweight → Equal Weight $135 → $146
Mar-26-21Downgrade BofA Securities Neutral → Underperform $127 → $118
Jan-05-21Downgrade BofA Securities Buy → Neutral $127
Feb-17-25 08:25AM
Feb-15-25 12:21PM
Feb-14-25 05:25PM
02:23PM
12:31PM
09:58AM Loading…
09:58AM
08:44AM
07:43AM
02:21AM
Feb-13-25 10:00PM
08:12PM
05:20PM
05:18PM
04:22PM
04:05PM
08:07AM Loading…
08:07AM
Feb-12-25 01:45PM
08:06AM
Feb-10-25 09:45AM
Feb-07-25 10:30AM
Feb-05-25 01:30PM
Feb-04-25 06:00PM
Feb-03-25 08:35AM
Feb-02-25 10:00AM
04:05AM
Jan-31-25 08:45AM
02:35AM
Jan-30-25 11:55AM
Jan-29-25 09:36PM
06:00PM
12:00PM Loading…
12:00PM
Jan-23-25 06:15PM
Jan-20-25 09:40AM
Jan-17-25 06:00PM
Jan-16-25 03:44PM
Jan-15-25 06:15PM
09:05AM
Jan-14-25 07:00PM
Jan-09-25 11:00AM
Jan-07-25 06:00PM
Jan-06-25 06:15PM
Jan-02-25 09:40AM
Dec-31-24 06:00PM
Dec-28-24 04:39PM
Dec-24-24 06:00PM
Dec-22-24 04:47AM
Dec-20-24 03:30PM
Dec-18-24 06:00PM
Dec-17-24 08:34PM
Nov-24-24 08:22AM
Nov-15-24 07:08PM
05:14PM
Nov-12-24 09:05AM
12:58AM
Nov-08-24 04:33PM
Oct-31-24 07:12PM
Oct-30-24 06:38PM
10:05AM
08:46AM
03:14AM
01:02AM
Oct-29-24 11:00PM
05:15PM
04:20PM
04:05PM
Oct-28-24 11:05AM
Oct-23-24 06:00PM
10:00AM
Oct-22-24 06:15PM
08:00AM
Oct-17-24 01:00PM
Oct-16-24 06:00PM
10:28AM
09:15AM
Oct-14-24 04:28PM
09:40AM
Oct-11-24 03:58PM
Oct-10-24 06:15PM
Oct-09-24 01:47PM
Oct-08-24 01:38PM
09:45AM
Oct-03-24 06:15PM
08:29AM
Sep-27-24 06:00PM
09:40AM
09:40AM
Sep-26-24 09:50AM
Sep-24-24 06:15PM
12:00PM
09:50AM
Sep-18-24 06:00PM
08:50AM
Sep-17-24 06:15PM
09:00AM
Sep-14-24 11:22AM
Sep-13-24 06:59PM
09:15AM
08:00AM
Sep-12-24 09:40AM
Sep-11-24 06:00PM
DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BERKSHIRE HATHAWAY INC10% OwnerFeb 11 '25Sale156.01203,09131,684,43035,892,479Feb 13 07:50 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffNov 27 '24Option Exercise108.938,078879,93797,706Nov 27 09:47 PM
Michael StaffieriOfficerNov 27 '24Proposed Sale167.097,9021,320,345Nov 27 03:29 PM
Michael StaffieriOfficerNov 18 '24Proposed Sale157.427,7861,225,664Nov 18 04:27 PM
Michael StaffieriOfficerNov 14 '24Proposed Sale155.947,4591,163,167Nov 14 04:05 PM
ACKERMAN JOELCFO and TreasuerSep 16 '24Option Exercise75.9578,9995,999,974185,740Sep 17 06:08 PM
Rodriguez JavierChief Executive OfficerSep 16 '24Sale165.0550,0008,252,515837,835Sep 17 06:07 PM
Rodriguez JavierChief Executive OfficerSep 13 '24Sale162.859,8811,609,122887,835Sep 17 06:07 PM
Javier RodriguezOfficerSep 16 '24Proposed Sale165.0550,0008,252,514Sep 16 05:47 PM
Michael StaffieriOfficerSep 16 '24Proposed Sale132.4137,2954,938,300Sep 16 05:47 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffAug 28 '24Option Exercise75.9526,3331,999,991109,344Aug 29 06:21 PM
ACKERMAN JOELCFO and TreasuerAug 27 '24Sale155.0664,0299,928,586111,481Aug 29 06:13 PM
ACKERMAN JOELCFO and TreasuerAug 28 '24Sale155.024,740734,785106,741Aug 29 06:13 PM
Rodriguez JavierChief Executive OfficerAug 26 '24Sale155.9332,1765,017,303905,659Aug 28 05:36 PM
Rodriguez JavierChief Executive OfficerAug 27 '24Sale155.937,9431,238,589897,716Aug 28 05:36 PM
Joel AckermanOfficerAug 27 '24Proposed Sale155.0073,64711,415,285Aug 27 04:21 PM
Javier RodriguezOfficerAug 26 '24Proposed Sale155.9350,0007,796,500Aug 26 05:34 PM
NEHRA JOHN Mformer board member Aug 26 '24Proposed Sale153.9030,0004,616,967Aug 26 03:42 PM
Rodriguez JavierChief Executive OfficerAug 20 '24Option Exercise67.80750,00050,850,0001,453,929Aug 22 05:38 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCAug 16 '24Sale150.1732,5804,892,382209,365Aug 19 06:35 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCAug 15 '24Sale150.039,5391,431,126241,945Aug 19 06:35 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffAug 13 '24Sale146.217,8571,148,76683,011Aug 15 06:05 PM
Michael StaffieriOfficerAug 15 '24Proposed Sale150.0142,1196,318,271Aug 15 04:16 PM
Kathleen WatersOfficerAug 13 '24Proposed Sale146.207,8571,148,724Aug 13 04:10 PM
DESOER BARBARA JDirectorMay 10 '24Sale138.815,030698,21410,954May 14 05:44 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCMar 13 '24Option Exercise52.4150,0002,620,500102,748Mar 15 06:13 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCMar 06 '24Option Exercise52.4150,0002,620,50087,687Mar 08 05:05 PM
ACKERMAN JOELCFO and TreasuerMar 06 '24Option Exercise52.4155,0002,882,550195,360Mar 08 05:04 PM
Rodriguez JavierChief Executive OfficerMar 06 '24Option Exercise67.80750,00050,850,0001,244,480Mar 08 05:04 PM
Rodriguez JavierChief Executive OfficerFeb 26 '24Option Exercise67.80450,00030,510,000889,002Feb 28 05:51 PM
Rodriguez JavierChief Executive OfficerFeb 28 '24Option Exercise67.8050,0003,390,000531,300Feb 28 05:51 PM
Rodriguez JavierChief Executive OfficerFeb 26 '24Sale126.1167,6038,525,130488,697Feb 28 05:51 PM
Rodriguez JavierChief Executive OfficerFeb 27 '24Sale126.877,397938,467481,300Feb 28 05:51 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCFeb 21 '24Option Exercise52.41100,0005,241,000137,687Feb 23 05:44 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCFeb 21 '24Sale119.8129,4883,533,02537,687Feb 23 05:44 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffFeb 21 '24Option Exercise52.4140,0002,096,400121,297Feb 23 05:44 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffFeb 21 '24Sale120.7311,2851,362,43881,297Feb 23 05:44 PM
ACKERMAN JOELCFO and TreasuerFeb 21 '24Option Exercise52.4155,0002,882,550178,726Feb 23 05:43 PM